FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
FLUTE Cross-border Prostate Cancer Data Standard Guide, published by Flute Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.eu/fhir/ig/flute/StructureDefinition/LM-StudyVariables | Version: 0.1.0 | |||
Draft as of 2025-04-24 | Computable Name: StudyVariables |
Study variables for a study on prostate cancer.
Usage:
Description of Profiles, Differentials, Snapshots and how the different presentations work.
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
This structure is derived from Base
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
This structure is derived from Base
Key Elements View
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
Differential View
This structure is derived from Base
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
Snapshot View
Name | Flags | Card. | Type | Description & Constraints![]() |
---|---|---|---|---|
![]() ![]() |
0..* | Base | Prostate Cancer study Variables | |
![]() ![]() ![]() |
1..1 | Reference(Patient) | Patient | |
![]() ![]() ![]() |
1..1 | integer | Age at the time of biopsy. Represents the patient's age when the biopsy was performed. | |
![]() ![]() ![]() |
1..1 | integer | Family history of prostate cancer. Indicates whether the patient has a known family history of prostate cancer (0: No, 1: Yes). | |
![]() ![]() ![]() |
1..1 | integer | Type of biopsy. Specifies whether the biopsy was an initial biopsy or a repeated one (0: initial, 2: repeated). | |
![]() ![]() ![]() |
1..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() |
1..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
![]() ![]() ![]() |
1..1 | Quantity | Prostate volume as determined by MRI. The measured volume of the prostate, typically reported in cubic centimeters (cc). | |
![]() ![]() ![]() |
1..1 | integer | PI-RADS score. The Prostate Imaging Reporting and Data System score used to assess prostate cancer risk on MRI. | |
![]() |
This structure is derived from Base